D3-creatine dilution, computed tomography and dual-energy X-ray absorptiometry for assessing myopenia and physical function in colon cancer: A cross-sectional study.
En ChengBette J CaanPeggy M CawthonWilliam J EvansMarc K HellersteinMahalakshmi ShankaranKristin L CampbellAlexandra M BinderBarbara SternfeldJeffrey A MeyerhardtKathryn H SchmitzElizabeth M Cespedes FelicianoPublished in: Journal of cachexia, sarcopenia and muscle (2023)
This is the first study using D3-creatine dilution method to assess muscle mass in a cancer population. Regardless of the techniques used for muscle or lean mass assessment, we observed stronger correlations, greater myopenia agreement, and more significant associations with physical function in men with colon cancer than women. D3Cr, CT and DXA are not interchangeable methods for assessing myopenia and physical function, especially in women with colon cancer. Future studies should consider relative advantages of these techniques and examine the D3-creatine dilution method in other cancer types.
Keyphrases
- dual energy
- computed tomography
- image quality
- papillary thyroid
- liquid chromatography tandem mass spectrometry
- positron emission tomography
- contrast enhanced
- squamous cell
- liquid chromatography
- magnetic resonance imaging
- skeletal muscle
- gas chromatography
- physical activity
- type diabetes
- polycystic ovary syndrome
- pregnant women
- metabolic syndrome
- body composition
- magnetic resonance
- bone mineral density
- young adults
- current status
- postmenopausal women
- insulin resistance
- tandem mass spectrometry
- adipose tissue
- solid phase extraction
- pregnancy outcomes